Features
News roundups
Announcements
Most Viewed      Most Discussed

One of science’s best tools for understanding obesity is debunking myths about metabolism

Quick Read

People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That’s not always a good idea

Quick Read

The FDA is powerless to stop them. The newly enacted right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate and dying patients

Quick Read

Part of a shameful medical history. In May 1951, a 35-year-old Boston woman who had been treated for years for ulcerative colitis and a variety of mental disorders — with little success — entered the Lahey Clinic in Burlington, Mass., to have a lobotomy

Quick Read

Stem cell clinics multiply, with heartbreaking results for some patients

Quick Read

(Video, watch now) In this panel discussion held at NYSCF headquarters, members of the John Hopkins Berman Institute of Bioethics, patient advocates, and scientists engaged in a discussion exploring the ethics and decision-making of stem cell treatments around the world. Featuring our Jeffrey Kahn, Francesco Clark, David Carmel and Susan Solomon

Quick Read

More than half of Americans take vitamin supplements, including 68 percent of those age 65 and older, according to a 2013 Gallup poll. Among older adults, 29 percent take four or more supplements of any kind, according to a Journal of Nutrition study published in 2017

Quick Read

Rats, mice, rabbits, and other animals have long been an essential part of testing drugs for safety and efficacy before they make their way to human subjects. But some scientists are trying to spare these animals, and even make drugs safer, by instead creating and relying on virtual test subjects

Quick Read